{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:58Z","timestamp":1747207318025,"version":"3.40.5"},"reference-count":36,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The present study aimed at characterizing the impact of the presence or absence of\nfluorine atoms on the phenyl and benzopyran rings of 4-phenyl(thio)ureido-substituted 2,2-\ndimethylchromans on their ability to inhibit insulin release from pancreatic \u03b2-cells or to relax vascular\nsmooth muscle cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Most compounds were found to inhibit insulin secretion and to provoke a marked\nmyorelaxant activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The lack of a fluorine or chlorine atom at the 6-position of the 2,2-dimethylchroman core\nstructure reduced the inhibitory activity on the pancreatic endocrine tissue. One of the most active\ncompounds on both tissues, compound 11h (BPDZ 678), was selected for further pharmacological\ninvestigations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The biological data suggested that 11h mainly expressed the profile of a KATP channel\nopener on pancreatic \u03b2-cells, although a calcium entry blockade effect was also observed. On vascular\nsmooth muscle cells, 11h behaved as a calcium entry blocker.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220221145500","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T04:30:59Z","timestamp":1645504259000},"page":"884-894","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research Advancements on Fluorinated and Non-Fluorinated 4-\nPhenyl(thio)ureido-Substituted 2,2-Dimethylchromans Acting as Inhibitors\nof Insulin Release and Smooth Muscle Relaxants"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-8257","authenticated-orcid":true,"given":"Bernard","family":"Pirotte","sequence":"first","affiliation":[{"name":"Laboratoire de Chimie Pharmaceutique, Center for Interdisciplinary Research on Medicines (CIRM), Universit\u00e9 de\nLi\u00e8ge, Quartier H\u00f4pital, Avenue Hippocrate 15, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Florence","sequence":"additional","affiliation":[{"name":"Laboratoire de Chimie Pharmaceutique, Center for Interdisciplinary Research on Medicines (CIRM), Universit\u00e9 de\nLi\u00e8ge, Quartier H\u00f4pital, Avenue Hippocrate 15, B-4000 Li\u00e8ge, Belgium"},{"name":"Laboratoire de Physiologie et Pharmacologie,\nUniversit\u00e9 Libre de Bruxelles, Facult\u00e9 de M\u00e9decine, 808 Route de Lennik, B-1070 Bruxelles, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Goffin","sequence":"additional","affiliation":[{"name":"Laboratoire de Chimie Pharmaceutique, Center for Interdisciplinary Research on Medicines (CIRM), Universit\u00e9 de\nLi\u00e8ge, Quartier H\u00f4pital, Avenue Hippocrate 15, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Leleux","sequence":"additional","affiliation":[{"name":"Laboratoire de Physiologie et Pharmacologie,\nUniversit\u00e9 Libre de Bruxelles, Facult\u00e9 de M\u00e9decine, 808 Route de Lennik, B-1070 Bruxelles, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lebrun","sequence":"additional","affiliation":[{"name":"Laboratoire de Physiologie et Pharmacologie, Universit\u00e9 Libre de Bruxelles, Facult\u00e9 de M\u00e9decine, 808 Route de Lennik, B-1070 Bruxelles, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1934578X0900400411","volume":"4","author":"Zheng Y.","year":"2009","unstructured":"Zheng Y.; Zhao B.; Lu C.; Lin X.; Zheng Z.; Su W.; Isolation, structure elucidation and apoptosis-inducing activity of new compounds from the edible fungus Lentinus striguellus. Nat Prod Commun 2009,4(4),501-506","journal-title":"Nat Prod Commun"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bse.2011.01.005","volume":"39","author":"Li S-G.","year":"2011","unstructured":"Li S-G.; Tian H-Y.; Ye W-C.; Jiang R-W.; Benzopyrans and furoquinoline alkaloids from Melicope pteleifolia. Biochem Syst Ecol 2011,39,64-67","journal-title":"Biochem Syst Ecol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1021\/acs.jnatprod.5b00673","volume":"79","author":"Fobofou S.A.T.","year":"2016","unstructured":"Fobofou S.A.T.; Franke K.; Porzel A.; Brandt W.; Wessjohann L.A.; Tricyclic acylphloroglucinols from Hypericum lanceolatum and regioselective synthesis of selancins A and B. J Nat Prod 2016,79(4),743-753","journal-title":"J Nat Prod"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1124\/jpet.111.190314","volume":"342","author":"Reilly R.M.","year":"2012","unstructured":"Reilly R.M.; McDonald H.A.; Puttfarcken P.S.; Joshi S.K.; Lewis L.; Pai M.; Franklin P.H.; Segreti J.A.; Neelands T.R.; Han P.; Chen J.; Mantyh P.W.; Ghilardi J.R.; Turner T.M.; Voight E.A.; Daanen J.F.; Schmidt R.G.; Gomtsyan A.; Kort M.E.; Faltynek C.R.; Kym P.R.; Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature. J Pharmacol Exp Ther 2012,342(2),416-428","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1021\/jm500916t","volume":"57","author":"Voight E.A.","year":"2014","unstructured":"Voight E.A.; Gomtsyan A.R.; Daanen J.F.; Perner R.J.; Schmidt R.G.; Bayburt E.K.; DiDomenico S.; McDonald H.A.; Puttfarcken P.S.; Chen J.; Neelands T.R.; Bianchi B.R.; Han P.; Reilly R.M.; Franklin P.H.; Segreti J.A.; Nelson R.A.; Su Z.; King A.J.; Polakow-ski J.S.; Baker S.J.; Gauvin D.M.; Lewis L.R.; Mikusa J.P.; Joshi S.K.; Faltynek C.R.; Kym P.R.; Kort M.E.; Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): A temperature-neutral Transient Receptor Potential Vanilloid-1 (TRPV1) antagonist with analgesic efficacy. J Med Chem 2014,57(17),7412-7424","journal-title":"J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1021\/jm4002154","volume":"56","author":"Hunt K.W.","year":"2013","unstructured":"Hunt K.W.; Cook A.W.; Watts R.J.; Clark C.T.; Vigers G.; Smith D.; Metcalf A.T.; Gunawardana I.W.; Burkard M.; Cox A.A.; Geck Do M.K.; Dutcher D.; Thomas A.A.; Rana S.; Kallan N.C.; DeLisle R.K.; Rizzi J.P.; Regal K.; Sammond D.; Groneberg R.; Siu M.; Purkey H.; Lyssikatos J.P.; Marlow A.; Liu X.; Tang T.P.; Spirocyclic \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) in-hibitors: From hit to lowering of Cerebrospinal Fluid (CSF) amyloid \u03b2 in a higher species. J Med Chem 2013,56(8),3379-3403","journal-title":"J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/jhet.1860","volume":"51","author":"Dhawan A.","year":"2014","unstructured":"Dhawan A.; Balwani S.; Prasad A.K.; Ghosh B.; Parmar V.S.; Synthesis and evaluation of 2,2-dimethylchroman derivatives as inhibi-tors of ICAM-1 expression on human endothelial cells. J Heterocycl Chem 2014,51,1712-1719","journal-title":"J Heterocycl Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1016\/j.bmcl.2013.06.006","volume":"23","author":"Ng R.A.","year":"2013","unstructured":"Ng R.A.; Sun M.; Bowers S.; Hom R.K.; Probst G.D.; John V.; Fang L.Y.; Maillard M.; Gailunas A.; Brogley L.; Neitz R.J.; Tung J.S.; Pleiss M.A.; Konradi A.W.; Sham H.L.; Dappen M.S.; Adler M.; Yao N.; Zmolek W.; Nakamura D.; Quinn K.P.; Sauer J.M.; Bova M.P.; Ruslim L.; Artis D.R.; Yednock T.A.; Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: Prime side chromane-containing inhibitors. Bioorg Med Chem Lett 2013,23(16),4674-4679","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1021\/acs.jmedchem.7b01339","volume":"61","author":"Wang X.","year":"2018","unstructured":"Wang X.; Liu B.; Searle X.; Yeung C.; Bogdan A.; Greszler S.; Singh A.; Fan Y.; Swensen A.M.; Vortherms T.; Balut C.; Jia Y.; Desino K.; Gao W.; Yong H.; Tse C.; Kym P.; Discovery of 4-[(2R,4R)-4-({[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV\/GLPG-2222), a potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector for the treatment of cystic fibrosis. J Med Chem 2018,61,1436-1449","journal-title":"J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2174\/0929867043365378","volume":"11","author":"Sebille S.","year":"2004","unstructured":"Sebille S.; De Tullio P.; Boverie S.; Antoine M-H.; Lebrun P.; Pirotte B.; Recent developments in the chemistry of potassium channel activators: The cromakalim analogs. Curr Med Chem 2004,11(9),1213-1222","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/jm000484+","volume":"44","author":"Coghlan M.J.","year":"2001","unstructured":"Coghlan M.J.; Carroll W.A.; Gopalakrishnan M.; Recent developments in the biology and medicinal chemistry of potassium channel modulators: Update from a decade of progress. J Med Chem 2001,44(11),1627-1653","journal-title":"J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/med.10060","volume":"24","author":"Mannhold R.","year":"2004","unstructured":"Mannhold R.; KATP channel openers: Structure-activity relationships and therapeutic potential. Med Res Rev 2004,24(2),213-266","journal-title":"Med Res Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2174\/156802606777323647","volume":"6","author":"Mannhold R.","year":"2006","unstructured":"Mannhold R.; Structure-activity relationships of K(ATP) channel openers. Curr Top Med Chem 2006,6(10),1031-1047","journal-title":"Curr Top Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/156802606777323683","volume":"6","author":"Cecchetti V.","year":"2006","unstructured":"Cecchetti V.; Tabarrini O.; Sabatini S.; From cromakalim to different structural classes of K(ATP) channel openers. Curr Top Med Chem 2006,6(10),1049-1068","journal-title":"Curr Top Med Chem"},{"key":"ref=15","first-page":"1609","volume":"39","author":"Zhang X.","year":"2011","unstructured":"Zhang X.; Zhao J.; Kang S.; Yi M.; You S.; Shin D-S.; Kim D-K.; A novel cromakalim analogue induces cell cycle arrest and apoptosis in human cervical carcinoma HeLa cells through the caspase- and mitochondria-dependent pathway. Int J Oncol 2011,39(6),1609-1617","journal-title":"Int J Oncol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1152\/ajpcell.1998.274.1.C25","volume":"274","author":"Yokoshiki H.","year":"1998","unstructured":"Yokoshiki H.; Sunagawa M.; Seki T.; Sperelakis N.; ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 1998,274(1),C25-C37","journal-title":"Am J Physiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.1997.77.4.1165","volume":"77","author":"Quayle J.M.","year":"1997","unstructured":"Quayle J.M.; Nelson M.T.; Standen N.B.; ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997,77(4),1165-1232","journal-title":"Physiol Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1113\/jphysiol.2006.105973","volume":"572","author":"Teramoto N.","year":"2006","unstructured":"Teramoto N.; Physiological roles of ATP-sensitive K+ channels in smooth muscle. J Physiol 2006,572(Pt 3),617-624","journal-title":"J Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/311271a0","volume":"311","author":"Cook D.L.","year":"1984","unstructured":"Cook D.L.; Hales C.N.; Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature 1984,311(5983),271-273","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0079-6107(02)00053-6","volume":"81","author":"Seino S.","year":"2003","unstructured":"Seino S.; Miki T.; Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 2003,81(2),133-176","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/bph.12407","volume":"171","author":"Tinker A.","year":"2014","unstructured":"Tinker A.; Aziz Q.; Thomas A.; The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system. Br J Pharmacol 2014,171(1),12-23","journal-title":"Br J Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2170\/jjphysiol.48.397","volume":"48","author":"Inagaki N.","year":"1998","unstructured":"Inagaki N.; Seino S.; ATP-sensitive potassium channels: Structures, functions, and pathophysiology. Jpn J Physiol 1998,48(6),397-412","journal-title":"Jpn J Physiol"},{"key":"ref=23","first-page":"187","volume":"176","author":"Ashcroft S.J.","year":"2000","unstructured":"Ashcroft S.J.; The beta-cell K(ATP) channel. J Membr Biol 2000,176(3),187-206","journal-title":"J Membr Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1021\/jm060161z","volume":"49","author":"Sebille S.","year":"2006","unstructured":"Sebille S.; Gall D.; de Tullio P.; Florence X.; Lebrun P.; Pirotte B.; Design, synthesis, and pharmacological evaluation of R\/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: Toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+\/-)-cromakalim. J Med Chem 2006,49(15),4690-4697","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1016\/j.bmc.2008.03.065","volume":"16","author":"Sebille S.","year":"2008","unstructured":"Sebille S.; de Tullio P.; Florence X.; Becker B.; Antoine M-H.; Michaux C.; Wouters J.; Pirotte B.; Lebrun P.; New R\/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+\/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers. Bioorg Med Chem 2008,16(10),5704-5719","journal-title":"Bioorg Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1016\/j.bmc.2009.09.041","volume":"17","author":"Florence X.","year":"2009","unstructured":"Florence X.; Sebille S.; Tullio Pd.; Lebrun P.; Pirotte B.; New R\/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: Modulation of the 4-position. Bioorg Med Chem 2009,17(22),7723-7731","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejmech.2014.04.024","volume":"80","author":"Florence X.","year":"2014","unstructured":"Florence X.; Desvaux V.; Goffin E.; de Tullio P.; Pirotte B.; Lebrun P.; Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: From potassium channel openers to calcium entry blockers? Eur J Med Chem 2014,80,36-46","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejmech.2016.05.042","volume":"121","author":"Pirotte B.","year":"2016","unstructured":"Pirotte B.; Florence X.; Goffin E.; Medeiros M.B.; de Tullio P.; Lebrun P.; 4-Phenylureido\/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky \u2018carbamate\u2019 moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion. Eur J Med Chem 2016,121,338-351","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/cmdc.201700409","volume":"12","author":"Pirotte B.","year":"2017","unstructured":"Pirotte B.; Florence X.; Goffin E.; Lebrun P.; Deciphering structure-activity relationships in a series of 2,2-dimethylchromans acting as inhibitors of insulin release and smooth muscle relaxants. ChemMedChem 2017,12(21),1810-1817","journal-title":"ChemMedChem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1039\/C8MD00593A","volume":"10","author":"Pirotte B.","year":"2019","unstructured":"Pirotte B.; Florence X.; Goffin E.; Lebrun P.; 2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazines as isosteres of 2,2-dimethylchromans acting as inhibitors of insulin release and vascular smooth muscle relaxants. MedChemComm 2019,10(3),431-438","journal-title":"MedChemComm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1126\/science.1131943","volume":"317","author":"M\u00fcller K.","year":"2007","unstructured":"M\u00fcller K.; Faeh C.; Diederich F.; Fluorine in pharmaceuticals: Looking beyond intuition. Science 2007,317(5846),1881-1886","journal-title":"Science"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/bs.pmch.2014.11.001","volume":"54","author":"Swallow S.","year":"2015","unstructured":"Swallow S.; Fluorine in medicinal chemistry. Prog Med Chem 2015,54,65-133","journal-title":"Prog Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","volume":"58","author":"Gillis E.P.","year":"2015","unstructured":"Gillis E.P.; Eastman K.J.; Hill M.D.; Donnelly D.J.; Meanwell N.A.; Applications of fluorine in medicinal chemistry. J Med Chem 2015,58(21),8315-8359","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bcp.2007.08.032","volume":"75","author":"Lebrun P.","year":"2008","unstructured":"Lebrun P.; Becker B.; Morel N.; Ghisdal P.; Antoine M-H.; de Tullio P.; Pirotte B.; KATP channel openers: Tissue selectivity of origi-nal 3-alkylaminopyrido- and 3-alkylaminobenzothiadiazine 1,1-dioxides. Biochem Pharmacol 2008,75(2),468-475","journal-title":"Biochem Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s001250051370","volume":"43","author":"Lebrun P.","year":"2000","unstructured":"Lebrun P.; Arkhammar P.; Antoine M-H.; Nguyen Q-A.; Hansen J.B.; Pirotte B.; A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 2000,43(6),723-732","journal-title":"Diabetologia"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","volume":"19","author":"Tetko I.V.","year":"2005","unstructured":"Tetko I.V.; Gasteiger J.; Todeschini R.; Mauri A.; Livingstone D.; Ertl P.; Palyulin V.A.; Radchenko E.V.; Zefirov N.S.; Makarenko A.S.; Tanchuk V.Y.; Prokopenko V.V.; Virtual computational chemistry laboratory--design and description. J Comput Aided Mol Des 2005,19(6),453-463","journal-title":"J Comput Aided Mol Des"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220221145500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201329\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220221145500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:15:19Z","timestamp":1693160119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201329\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220221145500","relation":{},"ISSN":["1573-4064"],"issn-type":[{"type":"print","value":"1573-4064"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}